ANG Lifesciences India Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

BSE: 540694 Small Cap ISIN: INE236W01016

As on 05 February 2025 at 23:29 IST

₹41.14

+ 0.94

(2.34%)

Sell Buy

Over 1 Month

-7.29%

Over 6 Months

-18.44%

Over 1 Year

-40.39%

Over 3 Years

-83.57%

ANG Lifesciences India Ltd Summary

Close ₹ 41.14

Open ₹ 41.89

High ₹ 41.89

Low ₹ 40.06

Volume 7,649

Net Turnover (in ₹ Cr) ₹ 0.031

52Wk High ₹ 70.49

52Wk Low ₹ 37.22

52Wk High / Low

37.22

ANG Lifesciences India Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 53.72

EPS (TTM) -

Book Value (BV) 56.15

Div. Yield -

P/E (TTM) -4.46

Price/Book Value 0.73

Delivery % 59.54 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 0.77

EV to Sales 0.86

PEG Ratio -

ROA -6.19

ROE -8.72

Debt-Equity 0.71

Net Profit Margin -5.40

Operating Profit Margin 7.78

ANG Lifesciences India Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	146.81	229.61	355.20	-	-
Total Expenses	155.79	226.99	301.70	-	-
Profit Before Tax	-10.71	2.62	53.50	-	-
Profit After Tax	-10.14	-0.26	40.32	-	-
Operating Profit after Depreciation	1.98	14.50	62.41	-	-

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	58.40	88.15	92.61	-	-
Total Non Current Assets	69.13	94.51	98.22	-	-
Total Current Assets	173.31	183.15	192.81	-	-
TOTAL ASSETS	242.44	277.66	291.03	-	-
Total Shareholder's Fund	76.28	86.22	83.77	-	-

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-9.49	26.38	24.72	-	-
Net Cash used in Investing Activities	19.89	-9.33	-44.41	-	-
Net Cash used in Financing Activities	-10.40	-17.07	19.93	-	-

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	132.20	216.85	349.62	155.02	127.25
Total Expenses	139.34	214.78	296.56	145.16	118.84
Profit Before Tax	-8.87	2.07	53.06	9.86	8.41
Profit After Tax	-8.65	-0.66	39.71	7.25	6.10
Operating Profit after Depreciation	2.20	12.39	60.91	13.44	11.27

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	53.35	78.68	82.32	21.89	21.17
Total Non Current Assets	59.05	84.30	87.12	30.35	21.40
Total Current Assets	158.37	168.21	181.57	111.89	72.67
TOTAL ASSETS	217.43	252.51	268.68	142.24	94.08
Total Shareholder's Fund	77.07	85.54	83.48	41.36	34.56

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-13.13	26.01	27.39	-11.18	4.83
Net Cash used in Investing Activities	20.02	-9.35	-42.50	-7.79	-1.66
Net Cash used in Financing Activities	-7	-16.75	15.29	18.81	-3.95

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	32.88	18.41	37.84	18.55	33.26
Total Expenses	30.60	20.12	34.48	20.46	31.61
Profit Before Tax	-1.29	-4.14	-4.08	-6.36	-2.64
Profit After Tax	-2.09	-3.07	-3.65	-5.93	-2.32
Operating Profit after Depreciation	2.63	-0.43	3.55	-1.94	1.87

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	32.16	16.18	34.08	17.10	29.58
Total Expenses	29.70	18.10	30.24	18.81	28.26
Profit Before Tax	-0.67	-3.74	-2.92	-5.81	-2.28
Profit After Tax	-1.07	-2.77	-3.60	-4.59	-2.05
Operating Profit after Depreciation	2.82	-0.56	4.09	-1.80	1.65

ANG Lifesciences India Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 39.39

S2 38.57

S3 37.27

Pivot 40.69

R1 41.51

R2 42.81

R3 43.63

Moving Average

20 SMA 41.33

50 SMA 43.99

100 SMA 46.34

200 SMA 49.27

ANG Lifesciences India Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 30 Sep 2022

AGM 30/09/2022 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015, this is to submit that the Board of Directors of the Company in its meeting held on today, September 05, 2022 has considered and approved the agendas herewith enclosed (As Per BSE Announcement dated on 05.09.2022) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the summary of proceedings of the 16th Annual General Meeting (AGM) held on Friday, September 30, 2022, at 12:00 p.m. through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM') in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India for transacting the business(es) mentioned in the Notice dated 05th September 2022 convening the AGM. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 30 Sep 2023

AGM Date: 30 Sep 2024

AGM 30/09/2024 Pursuant to Reg 42 of SEBI (LODR), 2015, the register of member and share transfer books of the company shall remain closed from 24.09.2024 to 30.09.2024 and cut off date will be 23.09.2024 (As Per BSE Announcement Dated on 07.09.2024) Please enclosed herewith the scrutinizer report for Annual General Meeting held on 30th September, 2024. (As Per BSE Announcement Dated on 02.10.2024) Please enclosed herewith the outcome of 18th Annual General Meeting held on 30.09.2024 through the VC/OAVM (As Per BSE Announcement Dated on 05.10.2024) Appointment of Statutory Auditor (As Per BSE Announcement Dated on 01.10.2024)

EGM Date: 10 Nov 2022

EGM 10/11/2022 Pursuant to Regulation 30 & 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of Newspaper Advertisement published on 20' October, 2022, one in the English Newspaper having nationwide circulation -Financial Express and one in Vernacular Newspaper - Desh Sewak intimating the) shareholders about Extra Ordinary General Meeting of our company to be held on 10' November, 2022 at 12:00 P.M through Video Conferencing/other Audio-Visual Means (OAVM). (As Per BSE Announcement Dated on 20/10/2022) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the summary of proceedings of the Extra Ordinary General Meeting (EGM) held on Thursday, November, 10, 2022, at 12:00 p.m. through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM') in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India for transacting the business(es) mentioned in the Notice dated 17th October, 2022 convening the EGM. (As Per BSE Announcement dated on 11.11.2022) We furnish herewith the results of remote e-voting & remote e-voting conducted at the Extra Ordinary General Meeting of the Company held on Thursday, 10th November, 2022, in respect of items of business;/agendas mentioned in Notice dated 17th October, 2022 ('EGM Notice') in the form prescribed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated 12.11.2022)

EGM Date: 01 Apr 2023

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that the Board of Directors of the Company have , considered and approved the following: 1. Increase in Authorised Share Capital of the Company 2. Issue, offer and allot upto 22,00,000 warrants convertible into 22,00,000 Equity Shares of Rs. 10 each on preferential basis to the ANG Capital Investments Private Limited. (Issue price of the Convertible warrants is Rs. 110.00 each. ) 3.Calling an Extra Ordinary General Meeting (EGM) and approved the Notice of Extra Ordinary General Meeting (EGM) of the Members of the Company for EGM to be held on Saturday, 1st April, 2023 at 12:00 P.M. through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM') Means 4. Appointment of M/s. Anjum Goyal & Associates, Practicing Company Secretary as Scrutinizer Pursuant to Regulation 30 read with Part A of Schedule III, we are enclosing herewith a copy of notice of the Extra Ordinary General Meeting (EGM) of ANG Lifesciences India Ltd ('the Company'') to be held on Saturday, 01st April, 2023 at 12:00 p.m. (IST) through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). The said Notice is being sent only through e-mails to the shareholders of the Company at their registered e-mail addresses and the same has also been uploaded on the website of the Company at www.anglifesciences.com The Company has fixed Saturday, 25th March, 2023 as the 'Cut-off-Date' for the purpose of determining the eligibility of the members entitled to vote by remote e-voting. Those shareholders holding shares either in dematerialized form or in physical form, as on the close of business hours on Saturday, 25th March, 2023 will be entitled to avail the facility of remote e-voting as well as voting at the EGM. (As Per BSE Announcement dated on 10.03.2023)

EGM Date: 03 May 2023

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that the Board of Directors of the Company in its meeting held on today, 05th April, 2023 at its registered office at SCO 113, Darbara Complex, First Floor, District Shopping Centre B Block, Ranjit Avenue, Amritsar, Punjab, 143001, have inter-alia discussed and considered the matters as per document enclosed. Pursuant to Regulation 30 read with Part A of Schedule III, we are enclosing herewith a copy of notice of the Extra Ordinary General Meeting (EGM) of ANG Lifesciences India Ltd ('the Company') to be held on Wednesday, 03rd May, 2023 at 12:00 p.m. (IST) through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). (As Per BSE Announcement Dated on 08.04.2023) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the summary of proceedings of the Extra Ordinary General Meeting (EGM) held on Wednesday, May, 03, 2023 at 12:00 p.m. through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM') in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India for transacting the business(es) mentioned in the Notice dated 05th April, 2023 convening the EGM. You are requested to take the same on record. (As per BSE Announcement Dated on 03/05/2023)

ANG Lifesciences India Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
ANG Lifesciences India Ltd	₹41.14	₹53.72
Sun Pharmaceuticals Industries Ltd	₹1,753.40	₹4,20,699.39
Divis Laboratories Ltd	₹6,124.40	₹1,62,583.58
Cipla Ltd	₹1,436.60	₹1,16,021.83
Torrent Pharmaceuticals Ltd	₹3,115.70	₹1,05,444.71
Dr Reddys Laboratories Ltd	₹1,227.95	₹1,02,463.09

ANG Lifesciences India Ltd News

ANG Lifesciences India to conduct board meeting

On 14 November 2024

11 Nov 2024, 01:04 pm

ANG Lifesciences India to hold AGM

On 30 September 2024

19 Sep 2024, 05:50 pm

ANG Lifesciences India to convene AGM

On 30 September 2024

19 Sep 2024, 10:10 am

ANG Lifesciences India to discuss results

On 14 August 2024

12 Aug 2024, 01:52 pm

ANG Lifesciences India to discuss results

On 30 May 2024

29 May 2024, 02:57 pm

ANG Lifesciences India Ltd Stock Analysis

Annual revenue for ANG Lifesciences India Ltd decreased by 39.03% to ₹132.20 crore in FY 2024 from ₹216.85 crore in FY 2023.
Annual Net Profit for ANG Lifesciences India Ltd increased by 1205.96% to ₹-8.65 crore in FY 2024 from ₹-0.66 crore in FY 2023.
Promoter Shareholding in ANG Lifesciences India Ltd remains unchanged by 0.00% in the most recent quarter, from 70.60% in September 2024 to 70.60% in December 2024.
ANG Lifesciences India Ltd delivered a 1-year return of -40.39% compared to the Nifty 50, which provided a return of 0% as of the last trading session.
ANG Lifesciences India Ltd share price moved up by 2.34% from its previous close of INR ₹40.20. The latest ANG Lifesciences India Ltd share price is INR ₹41.14.
ANG Lifesciences India Ltd share price today has been at a low of 40.06 and a high of 41.89. Over the past 52 weeks, the ANG Lifesciences India Ltd share price has seen a low of 37.22 and a high of 70.